Psilocybin as a Novel Therapy for Residual Anhedonia
Psilocybin as a Novel Therapy for Residual Anhedonia
Recruiting · NCT07607938 · Registry updated 2026-09-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Psilocybin as a Novel Therapy for Residual Anhedonia | Anhedonia, Neurobehavioral Manifestations, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, depressive disorder, nervous system disorder | Recruiting | Phase 1 | 2026-09-15 | NCT07607938 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Institute of Mental Health (NIMH) | 702 |
| NYU Langone Health | 359 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| NYU Langone Health | New York | United States | 403 |